기관지 생검 기기 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 지역별, 부문별 예측(2024-2030년)

Bronchial Biopsy Devices Market Growth & Trends:

The global bronchial biopsy devices market size is expected to reach USD 1.02 billion by 2030, growing at a CAGR of 7.39% from 2024 to 2030, according to a new report by Grand View Research, Inc. One of the major factors contributing to the growth of the market is the rising utilization of bronchial biopsy devices for diagnosing respiratory diseases and the increasing adoption of disposable devices. Moreover, rapid technological advancements and increasing awareness and screening regarding respiratory diseases also contribute to market expansion.

Advancements in medical technology are significantly driving the growth of the market by improving the precision, safety, and effectiveness of diagnostic procedures. Innovations such as EBUS-TBNA enable more accurate sampling of lung tissue, especially in difficult-to-reach areas. These minimally invasive techniques minimize patient discomfort, reduce the risk of complications, and shorten recovery times compared to traditional surgical methods. In addition, companies are entering the market with technologically advanced products to establish a strong presence. For instance, in May 2021, Olympus launched the BF-UC190F endobronchial ultrasound (EBUS) bronchoscope for lung cancer diagnosis and staging, thereby expanding its product portfolio.

Moreover, the increasing awareness and screening initiatives led by various organizations are significantly driving the demand for bronchial biopsy devices. With lung cancer being one of the most prevalent and deadly forms of cancer globally, organizations such as the American Lung Association and the WHO have intensified their efforts to promote early detection and diagnosis. In August 2024, in recognition of World Lung Cancer Day, the Forum of International Respiratory Societies, with the Global Initiative for Asthma as a founding member, emphasized the critical need for increased awareness, early screening, and improved access to lung cancer diagnosis & treatment.

Furthermore, the COVID-19 pandemic had a moderately negative impact on the bronchial biopsy device market, as evidenced by the disruption in lung cancer diagnosis and treatment observed during the early months of the pandemic. According to a study conducted by Elsevier Espana SLU, in July 2021, at a referral University Hospital in Spain, the mandatory confinement from March 23rd to June 21st, 2020, led to a substantial decrease in the number of lung cancer diagnoses. This decline was attributed to the cancellation or delay of medical consultations, diagnostic tests, and non-essential procedures, which resulted in a reduced number of lung biopsies & screening visits.

Bronchial Biopsy Devices Market Report Highlights:

• Based on product, the transbronchial needle aspiration (TBNA) needles segment held the largest revenue share of 62.18% in 2023 and is expected to register growth at the highest CAGR over the forecast period. Moreover, the cryobiopsy devices (cryoprobes) segment is anticipated to grow significantly over the forecast period
• The EBUS-TBNA segment held the largest market share in 2023, as it is a minimally invasive technique that allows for collecting tissue samples from the lungs and surrounding lymph nodes without requiring major surgery
• In 2023, North America dominated the market with a share of over 40%, owing to the robust healthcare infrastructure and rising adoption of innovative diagnostic tools
• Key players in the market are adopting several strategies such as partnership, collaboration, and product launch to expand their offering and increase their market share. For instance, in May 2024, Cook Medical, introduced AcuCore, a next-generation EchoTip AcuCore Endoscopic Ultrasound (EUS) Biopsy Needle in the U.S. It is employed with an ultrasound endoscope for FNB of extramural and submucosal lesions lymph nodes, mediastinal masses, and intraperitoneal masses within the GI tract

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Product
• 1.3. Estimates and Forecast Timeline
• 1.4. Research Methodology
• 1.5. Information Procurement
  • 1.5.1. Purchased Database
  • 1.5.2. GVR's Internal Database
  • 1.5.3. Secondary Sources
  • 1.5.4. Primary Research
• 1.6. Information Analysis
  • 1.6.1. Data Analysis Models
• 1.7. Market Formulation & Data Visualization
• 1.8. Model Details
  • 1.8.1. Commodity Flow Analysis
• 1.9. List of Secondary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Snapshot
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Rising utilization of bronchial biopsies for diagnosing lung cancer and related conditions
    • 3.2.1.2. Rising adoption of disposable devices
    • 3.2.1.3. Rapid technological advancements
    • 3.2.1.4. Increasing awareness and screening initiatives by organizations
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Availability of alternative solutions
  • 3.2.3. Market Opportunity Analysis
  • 3.2.4. Market Threat Analysis
• 3.3. Business Environment Analysis
  • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTLE Analysis
  • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Product Business Analysis

• 4.1. Product Market Share, 2023 & 2030
• 4.2. Product Segment Dashboard
• 4.3. Market Size & Forecasts and Trend Analysis, by Product, 2018 to 2030 (USD Million)
• 4.4. Biopsy Forceps
  • 4.4.1. Bronchial biopsy forceps market, by durability, 2018 - 2030 (USD Million)
  • 4.4.2. Disposable
    • 4.4.2.1. Disposable market, 2018 - 2030 (USD Million)
  • 4.4.3. Reusable
    • 4.4.3.1. Disposable market, 2018 - 2030 (USD Million)
• 4.5. Transbronchial needle aspiration (TBNA) needles
  • 4.5.1. Transbronchial needle aspiration (TBNA) needles market, 2018 - 2030 (USD Million)
  • 4.5.2. Conventional
    • 4.5.2.1. Conventional market, 2018 - 2030 (USD Million)
  • 4.5.3. EBUS-TBNA
    • 4.5.3.1. EBUS-TBNA market, 2018 - 2030 (USD Million)
• 4.6. Cytology Brushes
  • 4.6.1. Cytology brushes market, 2018 - 2030 (USD Million)
• 4.7. Cryobiopsy Devices
  • 4.7.1. Cryobiopsy devices market, by durability, 2018 - 2030 (USD Million)
  • 4.7.2. Disposable
    • 4.7.2.1. Disposable market, 2018 - 2030 (USD Million)
  • 4.7.3. Reusable
    • 4.7.3.1. Disposable market, 2018 - 2030 (USD Million)

Chapter 5. Regional Estimates & Trend Analysis by Component

• 5.1. Regional Market Share Analysis, 2023 & 2030
• 5.2. Regional Market Dashboard
• 5.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
• 5.4. North America
  • 5.4.1. North America bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.4.2. U.S.
    • 5.4.2.1. Key country dynamic
    • 5.4.2.2. Regulatory framework/reimbursement scenario
    • 5.4.2.3. U.S. bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.4.3. Canada
    • 5.4.3.1. Key country dynamic
    • 5.4.3.2. Regulatory framework/reimbursement scenario
    • 5.4.3.3. Canada bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.4.4. Mexico
    • 5.4.4.1. Key country dynamic
    • 5.4.4.2. Regulatory framework/reimbursement scenario
    • 5.4.4.3. Mexico bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
• 5.5. Europe
  • 5.5.1. Europe bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.5.2. UK
    • 5.5.2.1. Key country dynamic
    • 5.5.2.2. Regulatory framework/reimbursement scenario
    • 5.5.2.3. UK bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.5.3. Germany
    • 5.5.3.1. Key country dynamic
    • 5.5.3.2. Regulatory framework/reimbursement scenario
    • 5.5.3.3. Germany bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.5.4. France
    • 5.5.4.1. Key country dynamic
    • 5.5.4.2. Regulatory framework/reimbursement scenario
    • 5.5.4.3. France bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.5.5. Italy
    • 5.5.5.1. Key country dynamic
    • 5.5.5.2. Regulatory framework/reimbursement scenario
    • 5.5.5.3. Italy bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.5.6. Spain
    • 5.5.6.1. Key country dynamic
    • 5.5.6.2. Regulatory framework/reimbursement scenario
    • 5.5.6.3. Spain bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.5.7. Norway
    • 5.5.7.1. Key country dynamic
    • 5.5.7.2. Regulatory framework/reimbursement scenario
    • 5.5.7.3. Norway bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.5.8. Denmark
    • 5.5.8.1. Key country dynamic
    • 5.5.8.2. Regulatory framework/reimbursement scenario
    • 5.5.8.3. Denmark bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.5.9. Sweden
    • 5.5.9.1. Key country dynamic
    • 5.5.9.2. Regulatory framework/reimbursement scenario
    • 5.5.9.3. Sweden bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
• 5.6. Asia Pacific
  • 5.6.1. Asia Pacific bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.6.2. Japan
    • 5.6.2.1. Key country dynamic
    • 5.6.2.2. Regulatory framework/reimbursement scenario
    • 5.6.2.3. Japan bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.6.3. China
    • 5.6.3.1. Key country dynamic
    • 5.6.3.2. Regulatory framework/reimbursement scenario
    • 5.6.3.3. China bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.6.4. India
    • 5.6.4.1. Key country dynamic
    • 5.6.4.2. Regulatory framework/reimbursement scenario
    • 5.6.4.3. India bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.6.5. South Korea
    • 5.6.5.1. Key country dynamic
    • 5.6.5.2. Regulatory framework/reimbursement scenario
    • 5.6.5.3. South Korea bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.6.6. Australia
    • 5.6.6.1. Key country dynamic
    • 5.6.6.2. Regulatory framework/reimbursement scenario
    • 5.6.6.3. Australia bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.6.7. Thailand
    • 5.6.7.1. Key country dynamic
    • 5.6.7.2. Regulatory framework/reimbursement scenario
    • 5.6.7.3. Thailand bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
• 5.7. Latin America
  • 5.7.1. Latin America bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.7.2. Brazil
    • 5.7.2.1. Key country dynamic
    • 5.7.2.2. Regulatory framework/reimbursement scenario
    • 5.7.2.3. Brazil bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.7.3. Argentina
    • 5.7.3.1. Key country dynamic
    • 5.7.3.2. Regulatory framework/reimbursement scenario
    • 5.7.3.3. Argentina bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
• 5.8. MEA
  • 5.8.1. MEA bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.8.2. South Africa
    • 5.8.2.1. Key country dynamic
    • 5.8.2.2. Regulatory framework/reimbursement scenario
    • 5.8.2.3. South Africa bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.8.3. Saudi Arabia
    • 5.8.3.1. Key country dynamic
    • 5.8.3.2. Regulatory framework/reimbursement scenario
    • 5.8.3.3. Saudi Arabia bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.8.4. UAE
    • 5.8.4.1. Key country dynamic
    • 5.8.4.2. Regulatory framework/reimbursement scenario
    • 5.8.4.3. UAE bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.8.5. Kuwait
    • 5.8.5.1. Key country dynamic
    • 5.8.5.2. Regulatory framework/reimbursement scenario
    • 5.8.5.3. Kuwait bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 6. Competitive Landscape

• 6.1. Participant Overview
• 6.2. Company Market Position Analysis
• 6.3. Company Categorization
• 6.4. Strategy Mapping
• 6.5. Company Profiles/Listing
  • 6.5.1. Medtronic
    • 6.5.1.1. Overview
    • 6.5.1.2. Financial performance
    • 6.5.1.3. Product benchmarking
    • 6.5.1.4. Strategic initiatives
  • 6.5.2. Boston Scientific Corporation
    • 6.5.2.1. Overview
    • 6.5.2.2. Financial performance
    • 6.5.2.3. Product benchmarking
    • 6.5.2.4. Strategic initiatives
  • 6.5.3. Cook Medical
    • 6.5.3.1. Overview
    • 6.5.3.2. Financial performance
    • 6.5.3.3. Product benchmarking
    • 6.5.3.4. Strategic initiatives
  • 6.5.4. CONMED Corporation
    • 6.5.4.1. Overview
    • 6.5.4.2. Financial performance
    • 6.5.4.3. Product benchmarking
    • 6.5.4.4. Strategic initiatives
  • 6.5.5. Telemed Systems, Inc.
    • 6.5.5.1. Overview
    • 6.5.5.2. Financial performance
    • 6.5.5.3. Product benchmarking
    • 6.5.5.4. Strategic initiatives
  • 6.5.6. HOBBS MEDICAL INC
    • 6.5.6.1. Overview
    • 6.5.6.2. Financial performance
    • 6.5.6.3. Product benchmarking
    • 6.5.6.4. Strategic initiatives
  • 6.5.7. Becton, Dickinson and Company (BD)
    • 6.5.7.1. Overview
    • 6.5.7.2. Financial performance
    • 6.5.7.3. Product benchmarking
    • 6.5.7.4. Strategic initiatives
  • 6.5.8. Olympus Corporation
    • 6.5.8.1. Overview
    • 6.5.8.2. Financial performance
    • 6.5.8.3. Product benchmarking
    • 6.5.8.4. Strategic initiatives
  • 6.5.9. Horizons International Corp.
    • 6.5.9.1. Overview
    • 6.5.9.2. Financial performance
    • 6.5.9.3. Product benchmarking
    • 6.5.9.4. Strategic initiatives
  • 6.5.10. Argon Medical Devices
    • 6.5.10.1. Overview
    • 6.5.10.2. Financial performance
    • 6.5.10.3. Product benchmarking
    • 6.5.10.4. Strategic initiatives
  • 6.5.11. Erbe Elektromedizin GmbH
    • 6.5.11.1. Overview
    • 6.5.11.2. Financial performance
    • 6.5.11.3. Product benchmarking
    • 6.5.11.4. Strategic initiatives